Mercks, WELIREG

Merck's WELIREG Entry Brings New Momentum to Pheochromocytomas and Paragangliomas Therapeutics Market | DelveInsight

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United Kingdom United States of America

 
+14699457679

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/mercks-welireg-entry-brings-new-momentum-to-pheochromocytomas-and-paragangliomas-therapeutics-market--delveinsight-302466634.html

en | boerse | 67931321 |